Results 291 to 300 of about 117,699 (379)

Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia

open access: yesJIMD Reports, Volume 66, Issue 4, July 2025.
ABSTRACT Little is known about pregnancies and placental changes in women with glycogen storage disease type Ia (GSD Ia). We report on two primipara with GSD Ia who both developed preeclampsia and whose newborns were small for gestational age. Both placentas showed sonomorphological and macroscopical abnormalities.
V. Laufs   +7 more
wiley   +1 more source

Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease. [PDF]

open access: yesAm J Pathol, 2018
Puri P   +6 more
europepmc   +1 more source

Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression

open access: yesThe Journal of Pathology, Volume 266, Issue 3, Page 352-367, July 2025.
Abstract Clear cell ovarian cancer (CCOC) is the second most common ovarian cancer subtype, accounting for 5%–11% of ovarian cancers in North America. Late‐stage CCOC is associated with a worse prognosis compared to other ovarian cancer histotypes, a challenge that has seen limited progress in recent decades.
Amal M EL‐Naggar   +27 more
wiley   +1 more source

Molecular Detection of Neospora Caninum in Different Tissues of Dogs and Cats in Shiraz, Iran

open access: yesVeterinary Medicine and Science, Volume 11, Issue 4, July 2025.
Neospora caninum is one of the most critical causative agents of abortion in dairy cattle. The canidae, especially dogs. This parasite causes neuromuscular disease in dogs. The objective of this research was to determine the molecular characterisation of N. caninum in different tissues of dogs and cats ABSTRACT Background Neospora caninum is one of the
Gholam Reza Hatam   +4 more
wiley   +1 more source

A Novel Inhibitor of Methyltransferase SMYD2, AZ505 Protects Against Peritoneal Fibrosis in Mice

open access: yesClinical and Experimental Pharmacology and Physiology, Volume 52, Issue 7, July 2025.
AZ505, a highly selective inhibitor of SMYD2, may exhibit an antifibrotic effect in peritoneal fibrosis. ABSTRACT AZ505, a highly selective inhibitor of SMYD2, exhibits an antifibrotic effect in renal fibrosis. Its effect on peritoneal fibrosis remains unexplored.
Taijing Xu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy